Biologo Stefania Motta

Meet Stefania Motta: Master’s Degree in biology, Cosmetologist and specialized in Hygiene and Preventive Medicine.

Since her year at the University of Milano as a researcher, Stefania had a vision, a line of safe and effective products to help people with skin problems.

After an intense research on cosmetics available on the market it was clear that many products when formulated with too many ingredients, often without a specific action, many not safe for the skin and some innovative with not proven efficacy.

Her vision soon became her dream to create a line of products formulated with a minimum amount of safe, effective and nontoxic ingredients. But, most importantly products that can be use in the presence of the most common skin conditions without side effects.

In the year 2000 the first few products of the MOST line started to reach the market and with the collaborations of other professionals including dermatologists and researchers, Stefania keeps researching and elaborating solutions for new products to address specific conditions.

The MOST line products can be called “cosmeceutical”, a rather new definition of those products that are indeed cosmetics but have therapeutic properties because when you have sensitive skin or a skin condition your skin should “feel” good not just “look” good.

Her passion for quality permeate every single aspect of her work such as the meticulous choice of the ingredients, the personal participation in the manufacturing process and the constant research for packaging reduction and recycling.

Career

  • President and CEO of Unionderma SRL, producing skin care products with MOST trademark and veterinany products with DERMALIAS trademark.
  • President and CEO of MOSTUSA LLC, the United States of America based company distributing products of the MOST skin care line.
  • President of the Italian Society of Chemistry and Cosmetology Science (SICC)
  • From 1990 to 2017 was a teacher and researcher at the Dermatology Institute of the University of Milan and in the Dermatology Task Force of the Department of Translational Medicine at the “Istituto Clinico Humanitas” in Milan.

Studies

  • In 1985 obtains A master Degree in Biology Science
  • Between 1985 and 1990 specializes in Cosmetic Science and Technology at the University of Ferrara and Hygiene and preventive medicine at the University of Milan.

Publications

Stefania Motta is the author of over 50 publications, here some of the most significant ones:

  1. Monti M, Motta S (2012). Italian dermatologic experience on nonmelanoma skin cancers (NMSCS) with temoporfin-PDT. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, vol. 66, p. AB153, ISSN: 0190-9622
  2. Monti M, Motta S (2012). Temoporfin PDT partial response of multiple head-and-neck skin epitheliomas: Implication of warfarin. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, vol. 66, p. AB158, ISSN: 0190-9622
  3. Monti M, Motta S (2009). Photodynamic therapy in skin ulcer closure. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, vol. 60, p. AB200, ISSN: 0190-9622
  4. Motta S, Kanah David, Monti Marcello (2009). Treatment of acne: Photodynamic therapy and micropeeling. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, vol. 60, p. AB17, ISSN: 0190-9622
  5. M. Monti, S. Motta (2007). Clinical management of cutaneous toxicity of anti-EGFR agents. THE INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, vol. 22, p. S53-S61, ISSN: 0393-6155
  6. M. Monti, S. Motta (a cura di) (2007). La psoriasi. Riflessioni e consigli pratici. Milano:Interaction
  7. S. Motta, M. Monti (2007). Photodynamic therapy-a promising treatment option for autoimmune skin ulcers: a case report. PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES, vol. 6, p. 1150-1151, ISSN: 1474-905X, doi: 10.1039/b711920h
  8. S. Motta, L.L. Mancini, M.R. Monti (2006). Cutaneous effects of anti-EGFR cetuximab : dermatological management. SUPPORTIVE AND PALLIATIVE CANCER CARE, vol. 2, p. 105-108, ISSN: 1824-601X
  9. M.R. Monti, S. Motta (a cura di) (2005). Manuale di Terapia Fotodinamica in Dermatologia. Milano:Lampi di Stampa, ISBN: 88-488-0409-8
  10. M. Monti, S. Motta, L.L. Mancini (2005). La medicazione delle ulcere cutanee mediante unguento ai PEG con allantoina. MEDICINA CLINICA E TERMALE, vol. 18, p. 34-36
  11. M. Monti, S. Motta (2005). ALA-PDT pain control reducing incubation. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, vol. 19, p. 240, ISSN: 0926-9959
  12. S. Motta, M. Monti (2005). Skin rejuvenation using micro-peeling and short incubation 5% ALA-PDT. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, vol. 19, p. 19
  13. S. Motta (2005). La terapia fotodinamica combinata nel trattamento del fotodanneggiamento cronico. In: M. Monti;S. Motta. Manuale di terapia fotodinamica in dermatologia. p. 165-173, Milano:Lampi di Stampa, ISBN: 88-488-0409-8
  14. M. Monti, S. Motta (2005). Le nuove frontiere dell’idratazione cutanea: l’autoidratazione cornea. MEDICINA ESTETICA, vol. 29, p. 142, ISSN:
  15. Monti M, Motta S (2004). Polydecene oljgomers versus mineral oils: The rationale for use in dermatological preparations. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, vol. 50, p. P75, ISSN: 0190-9622 , doi: 10.1016/j.jaad.2003.10.624
  16. Monti M, Motta S (2004). Preliminary study on virtual dermatological examination using mobile video phone. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, vol. 50, p. P82, ISSN: 0190-9622 , doi: 10.1016/j.jaad.2003.10.653
  17. Motta S, Monti M, Franceschini B, Russo C (2004). Quantitative analysis of tumor infiltrating lymphocytes in cutaneous melanoma. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, vol. 50, p. P119, ISSN: 0190-9622 , doi: 10.1016/j.jaad.2003.10.400
  18. Motta S, Sala G, Monti M (1997). Sebaceous lipids analysed by two different extraction methods. JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 108, p. 21, ISSN: 0022-202X
  19. Monti M, Motta S, Sala G (1997). Skin surface lipids: Comparison between forehead and forearm. JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 108, p. 20, ISSN: 0022-202X
  20. Monti M, Motta S, Sala G (1997). Skin surface lipids: Comparison between forehead and forearm. JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 108, p. 20, ISSN: 0022-202X
  21. Monti M, Motta S, Parolari E, Sesana S, Ghidoni R (1996). Influence of topical retinoic acid on interlamellar lipid synthesis. JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 106, p. 351, ISSN: 0022-202X
  22. Motta S, Sesana S, Ghidoni R, Monti M (1995). Content Of The Different Lipid Classes In Psoriatic Scale. ARCHIVES OF DERMATOLOGICAL RESEARCH, vol. 287, p. 691-694, ISSN: 0340-3696 , doi: 10.1007/BF00371745
  23. Motta S, Monti M, Sesana S, Mellesi L, Ghidoni R, Caputo R (1994). Abnormality Of Water Barrier Function In Psoriasis – Role Of Ceramide Fractions. ARCHIVES OF DERMATOLOGY, vol. 130, p. 452-456, ISSN: 0003-987X, doi: 10.1001/archderm.130.4.452
  24. Motta S, Sesana S, Monti M, Giuliani A, Caputo R (1994). Interlamellar Lipid Differences Between Normal And Psoriatic Stratum-Corneum. ACTA DERMATO-VENEREOLOGICA, vol. 74, p. 131-132, ISSN: 0001-5555
  25. Barbareschi M, Colzani G, Motta S, Angius A, Sesana S, Monti M (1994). Psoriatic Scales – An Ultrastructural-Study. ACTA DERMATO-VENEREOLOGICA, vol. 74, p. 35-36, ISSN: 0001-5555
  26. Motta S, Monti M, Sesana S, Caputo R, Carelli S, Ghidoni R (1993). Ceramide Composition Of The Psoriatic Scale. BIOCHIMICA ET BIOPHYSICA ACTA, vol. 1182, p. 147-151, ISSN: 0006-3002, doi: 10.1016/0925-4439(93)90135-N
  27. Caputo R, Monti M, Motta S, Barbareschi M, Tosti A, Serri R, Rigoni C (1990). The treatment of visible signs of senescence: the Italian experience.. BRITISH JOURNAL OF DERMATOLOGY, vol. 122 Suppl 35, p. 97-103, ISSN: 0007-0963, doi: 10.1111/j.1365-2133.1990.tb16133.x
  28. Monti M, Bozzetti M, Motta S, Barbareschi M (1989). Usefulness of surface topography analysis in psoriatic skin.. ACTA DERMATO-VENEREOLOGICA. SUPPLEMENTUM, vol. 146, p. 81-83, ISSN: 0365-8341